NanoViricides, Inc.NNVCNYSE

Revenue (LTM)

Net Income (LTM)

$-9M

-14.1% YoY

Free Cash Flow

$-9M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-9	-8↑7.2%	-9↓10.2%	-9↑4.8%	-10↓12.6%
Net Income	-9	-8↑8.1%	-9↓5.9%	-8↑3.4%	-9↓14.1%
EBITDA	-8	-7↑8.2%	-8↓6.3%	-7↑4.5%	-9↓16.5%
EPS Diluted	-0.81	-0.70↑13.6%	-0.74↓5.7%	-0.70↑5.4%	-0.63↑10.0%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Cash & Equivalents	21	14↓31.4%	8↓42.1%	5↓41.1%	2↓67.5%
Total Current Assets	21	14↓30.8%	8↓41.4%	5↓41.1%	2↓66.4%
Total Assets	30	23↓22.4%	17↓28.1%	13↓24.1%	9↓31.2%
Total Current Liabilities	0	0↑17.6%	1↑29.4%	1↑154.3%	1↓3.8%
Total Liabilities	0	0↑17.6%	2↑392.7%	1↓33.2%	1↓3.8%
Total Equity	30	23↓22.8%	15↓35.6%	11↓22.9%	8↓34.4%
Total Debt	0	0↓0.5%	0	0	0
Net Debt	-20	-14↑31.6%	-8↑41.7%	-5↑41.1%	-2↑67.5%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Operating Cash Flow	-8	-6↑28.3%	-6↑3.8%	-6↓11.4%	-8↓34.3%
Capital Expenditure	-0	-0↓35.8%	-0↑53.2%	-0↓3.2%	-0↑63.6%
Free Cash Flow	-8	-6↑26.5%	-6↑6.3%	-6↓11.2%	-9↓31.9%
Stock-Based Comp	0	0↓16.6%	0↓36.7%	0↑3.7%	0↑0.5%
Net Change in Cash	7	-6↓194.7%	-6↑8.3%	-3↑43.3%	-3↑3.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance